FDA Inspection 1136679 — Norwich Pharmaceuticals, Inc.
The FDA completed an inspection of Norwich Pharmaceuticals, Inc. on March 16, 2021 in Norwich, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 16, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Norwich, NY (United States)